Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Two racehorses test positive for banned substance
Under World Anti-Doping Agency Rules, EPO has been banned for use by human athletes since the 1990s. (stock photo)
FEI reveals positive drugs tests conducted in Doha
 
Two horses and their riders have tested positive for the banned substance human Erythropoietin (EPO).  

Samples taken on 22 April from a race in Doha contained the substance banned under the FEI’s Equine Anti Doping and Controlled Medication Regulations.

The winning horse Centurion, and second placed horse SUR, returned positive samples of EPO, a performance-enhancing drug, banned for equine use since 2010.

FEI veterinary director Göran Akerström said: “EPO is well known in human endurance sports in which an increased number of oxygen-carrying red blood cells is an advantage, but the substance has little benefit in equestrian sport and this is the first time we have seen FEI horses testing positive for EPO”.

Under World Anti-Doping Agency Rules, EPO has been banned for use by human athletes since the 1990s. It is a peptide hormone that is released from the kidneys to stimulate bone marrow to produce red blood cells. This improves blood oxygenation in the muscles.  

However, Akerström continued: “The use of EPO would have a negative effect in many horses as the increased level of red blood cells would slow down blood circulation.”

FEI secretary general Sabrina Ibanez said: “We will take whatever measures are necessary to ensure that there is no room in our sport for those who attempt to gain a competitive advantage through the use of prohibited substances”.

The horses and jockeys have commenced provisional two-month suspensions effective from the date of notification, 2 June, 2016.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.